ELTX- Elicio Therapeutics, Inc.

Name: Elicio Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Elicio Therapeutics, Inc. (ELTX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ELTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Chudnovsky Yekaterina	103.2K	$1.04M	-
Other	Haqq Christopher	57.4K	$579.0K	-
Dir	Venkatesan Jay	7.9K	$79.7K	-
Dir	Nissenson Allen	7.9K	$79.7K	-
Dir	Ruffolo Robert R	7.9K	$79.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 18, 2021	Neylan John F.95	See Remarks	Sell	381	$9.03	$3,440.43	-1.0%	-54.6%	-89.0%
Aug 16, 2021	Rhodes Jennifer J95	See Remarks	Sell	445	$10.68	$4,752.60	-1.4%	-59.2%	-90.0%
Jul 21, 2021	Rhodes Jennifer J95	See Remarks	Sell	432	$10.94	$4,726.08	-1.3%	-25.2%	-90.8%
Jul 21, 2021	Neylan John F.95	See Remarks	Sell	365	$10.98	$4,007.70	-1.0%	-25.2%	-90.8%
Jul 14, 2021	Rhodes Jennifer J95	See Remarks	Sell	431	$11.01	$4,745.31	-1.3%	-16.9%	-89.9%
Jun 18, 2021	Neylan John F.95	See Remarks	Sell	366	$13.20	$4,831.20	-1.0%	-19.4%	-89.9%
Jun 14, 2021	Rhodes Jennifer J95	See Remarks	Sell	427	$13.27	$5,666.29	-1.3%	-17.7%	-87.9%
May 18, 2021	Neylan John F.95	See Remarks	Sell	363	$13.91	$5,049.33	-1.0%	-28.0%	-92.3%
May 14, 2021	Rhodes Jennifer J95	See Remarks	Sell	440	$13.92	$6,124.80	-1.3%	-22.9%	-90.8%
Apr 19, 2021	Neylan John F.95	See Remarks	Sell	381	$13.55	$5,162.55	-1.0%	-20.9%	-87.5%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC